Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
Promoting physical activity to control multiple sclerosis from childhood.
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
Modulators of Microglia: a Patent Review.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
[Neuromyelitis optica in children. Two case reports.]
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Fluctuations of MS births and UV-light exposure.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.
Treatment of Acute Relapses in Multiple Sclerosis.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.

Pages